<Anchor>



Even if Vice Chairman Lee Jae-yong is released this Friday, the measures that restrict employment according to the law will still apply. Also, as you have heard earlier, it is predicted that it will not be easy for Vice Chairman Lee to participate in the business in earnest because he is being tried separately for Samsung Bio's accounting fraud and illegal propofol administration.



Next is reporter Han Sang-woo.



<Reporter>



Samsung did not make an official position on the parole of Vice Chairman Lee Jae-yong.



It seems that he was conscious of the controversy over preferential treatment, but he did not hide his expectation that the speed of decision-making within the group would be faster.



An official from Samsung Electronics said, "It seems that decision-making on a lot of pending issues will gain momentum."



While Vice Chairman Lee was imprisoned, in memory semiconductors, competitors such as Micron continued to chase, and in the foundry sector, the gap with Taiwan's TSMC, the No.



For this reason, the industry expects that the vice chairman will re-examine the semiconductor supergap strategy after returning.



A final decision to invest in the US, which is struggling among Texas, Arizona and New York amid the global semiconductor supply shortage, is also expected to be made.



In addition, mergers and acquisitions, which were suspended in 2017 by Harman, can be visualized in areas such as artificial intelligence, 5G, electric field, and automotive semiconductors.



The market showed expectations, such as when foreigners turned to buy Samsung Electronics and the share price recovered to 80,000 won.



However, at the same time, criticism may be raised that global companies with sales exceeding KRW 230 trillion cannot make future investment decisions due to the absence of a single head.



However, in principle, it is difficult to return to the business field and overseas business trips are restricted as the employment restrictions apply to parole.



In addition, due to ongoing trials such as Samsung Biologics accounting fraud, full-fledged management and external activities are expected to be restricted.



(Video coverage: Yang Doo-won, video editing: Won-hee Won)